FGFR1 overexpression and activation also upregulate ZEB-1 to promote EMT and EGFR inhibitor resistance in NSCLC cells 18, and increase the release of inflammatory chemokines such as CXCL1/5 to promote mammary tumor growth and progression 19. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.